Ownership stake · Activity not yet classified
Functional Formularies
Transaction overview
Reported completed
Announced:
Exact closing date not established.
Swander Pace reported completing its sale of Functional Formularies to Danone.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Swander Pace Capital Completes Sale of Functional Formularies to Danone ↗
Swander Pace Capital · Published May 1, 2024
The title reports completion and the dated body announces the sale to Danone; no separate closing date is given.